嘉实中证医疗指数发起式C(014603)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
18,839,932.65 |
7,272,353.41 |
-58,636,936.93 |
-75,423,332.12 |
| 利息合计 |
11,460.25 |
7,589.60 |
147,456.06 |
134,100.23 |
| 其中:存款利息收入 |
11,460.25 |
7,589.60 |
31,774.12 |
18,418.29 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-16,806,205.85 |
-16,575,218.96 |
-64,194,048.42 |
-36,447,876.17 |
| 其中:股票投资收益 |
-19,829,322.11 |
-18,823,940.25 |
-67,756,648.08 |
-38,673,098.30 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
366.65 |
366.65 |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
3,022,749.61 |
2,248,354.64 |
3,562,599.66 |
2,225,222.13 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
35,503,604.15 |
23,764,092.05 |
4,999,415.79 |
-39,138,296.65 |
| 其他收入 |
131,074.10 |
75,890.72 |
410,239.64 |
28,740.47 |
| 费用 |
1,993,869.79 |
1,063,162.48 |
2,289,319.46 |
1,179,495.49 |
| 管理人报酬 |
1,129,557.65 |
602,853.22 |
1,289,986.16 |
658,652.74 |
| 基金托管费 |
225,911.50 |
120,570.64 |
257,997.20 |
131,730.51 |
| 销售服务费 |
474,949.55 |
259,456.34 |
578,295.95 |
299,712.65 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
163,451.09 |
80,282.28 |
162,623.71 |
88,983.15 |
| 利润总额 |
16,846,062.86 |
6,209,190.93 |
-60,926,256.39 |
-76,602,827.61 |